Takashi Komeno

2.1k total citations · 1 hit paper
22 papers, 1.5k citations indexed

About

Takashi Komeno is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Takashi Komeno has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Takashi Komeno's work include Viral Infections and Outbreaks Research (15 papers), Viral Infections and Vectors (12 papers) and Fire effects on ecosystems (5 papers). Takashi Komeno is often cited by papers focused on Viral Infections and Outbreaks Research (15 papers), Viral Infections and Vectors (12 papers) and Fire effects on ecosystems (5 papers). Takashi Komeno collaborates with scholars based in Japan, United States and Philippines. Takashi Komeno's co-authors include Yousuke Furuta, Takaaki Nakamura, Brian B. Gowen, Kazumi Takahashi, Hiroshi Nishikawa, Nobuhiko Nomura, Atsushi Yoshida, Heinz Feldmann, Kyle Rosenke and Kyo Noguchi and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Takashi Komeno

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

2017 790 citations Yousuke Furuta, Takashi Komeno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takashi Komeno Japan	13	1.2k	470	215	203	154	22	1.5k
Els Keyaerts Belgium	22	1.7k 1.5×	448 1.0×	333 1.5×	136 0.7×	186 1.2×	50	2.6k
Naganori Nao Japan	19	1.7k 1.5×	546 1.2×	296 1.4×	89 0.4×	209 1.4×	41	2.2k
Robert M. Cox United States	21	808 0.7×	660 1.4×	236 1.1×	108 0.5×	88 0.6×	57	1.6k
Ahmed S. Abdel‐Moneim Saudi Arabia	24	1.1k 0.9×	563 1.2×	343 1.6×	72 0.4×	86 0.6×	114	2.1k
Leen Vijgen Belgium	23	2.0k 1.7×	936 2.0×	363 1.7×	127 0.6×	185 1.2×	62	3.1k
Julien Andréani France	19	976 0.8×	221 0.5×	400 1.9×	79 0.4×	111 0.7×	57	1.9k
Amy C. Shurtleff United States	19	1.0k 0.9×	338 0.7×	229 1.1×	291 1.4×	40 0.3×	30	1.4k
Tina Thomas United States	18	1.1k 0.9×	230 0.5×	182 0.8×	195 1.0×	231 1.5×	25	1.5k
Leon Caly Australia	15	1.8k 1.6×	402 0.9×	493 2.3×	200 1.0×	320 2.1×	31	2.6k

Countries citing papers authored by Takashi Komeno

Since Specialization

Citations

This map shows the geographic impact of Takashi Komeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Komeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Komeno more than expected).

Fields of papers citing papers by Takashi Komeno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Komeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Komeno. The network helps show where Takashi Komeno may publish in the future.

Co-authorship network of co-authors of Takashi Komeno

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Komeno. A scholar is included among the top collaborators of Takashi Komeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Komeno. Takashi Komeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tobiume, Minoru, Masaaki Satoh, Hirofumi Kato, et al.. (2023). Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection. Antiviral Research. 213. 105582–105582. 4 indexed citations

Kimitsuki, Kazunori, Sakirul Khan, Takaaki Yahiro, et al.. (2022). Implications of the antiviral drug favipiravir on rabies immunoglobulin for post-exposure prophylaxis of rabies in mice model with category III-like exposures. Antiviral Research. 209. 105489–105489. 6 indexed citations

Fujii, H, Hideki Tani, Satoshi Taniguchi, et al.. (2022). Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV. Viruses. 14(8). 1668–1668. 12 indexed citations

Komeno, Takashi, et al.. (2022). Analysis of the responsible site for favipiravir resistance in RNA-dependent RNA polymerase of influenza virus A/PR/8/34 (H1N1) using site-directed mutagenesis. Antiviral Research. 205. 105387–105387. 2 indexed citations

Nishi, Tatsuya, Katsuhiko Fukai, Kentaro Masujin, et al.. (2022). Administration of the antiviral agent T-1105 fully protects pigs from foot-and-mouth disease infection. Antiviral Research. 208. 105425–105425. 6 indexed citations

Yamada, Hiroshi, Satoshi Taniguchi, Masayuki Shimojima, et al.. (2021). M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening. Viruses. 13(6). 1061–1061. 5 indexed citations

Kato, Hirofumi, Mutsuyo Takayama‐Ito, Masaaki Satoh, et al.. (2021). Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus. PLoS neglected tropical diseases. 15(7). e0009553–e0009553. 5 indexed citations

Hawman, David W., Elaine Haddock, Kimberly Meade‐White, et al.. (2020). Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antiviral Research. 181. 104858–104858. 23 indexed citations

Julander, Justin G., et al.. (2020). Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus. Antiviral Research. 182. 104904–104904. 9 indexed citations

10.

Westover, Jonna B., Brady T. Hickerson, Arnaud J. Van Wettere, et al.. (2019). Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice. Pathogens. 8(4). 158–158. 13 indexed citations

11.

Yamada, Kentaro, Kyo Noguchi, Kazunori Kimitsuki, et al.. (2019). Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis. Antiviral Research. 172. 104641–104641. 30 indexed citations

12.

Tani, Hideki, Takashi Komeno, Aiko Fukuma, et al.. (2018). Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration. PLoS ONE. 13(10). e0206416–e0206416. 32 indexed citations

13.

Hawman, David W., Elaine Haddock, Kimberly Meade‐White, et al.. (2018). Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Research. 157. 18–26. 60 indexed citations

14.

Dawes, Brian E., Birte Kalveram, Tetsuro Ikegami, et al.. (2018). Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Scientific Reports. 8(1). 7604–7604. 106 indexed citations

15.

Rosenke, Kyle, Heinz Feldmann, Jonna B. Westover, et al.. (2018). Use of Favipiravir to Treat Lassa Virus Infection in Macaques. Emerging infectious diseases. 24(9). 1696–1699. 76 indexed citations

16.

Gowen, Brian B., Jonna B. Westover, Eric J. Sefing, et al.. (2017). Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy. Antiviral Research. 145. 131–135. 15 indexed citations

17.

Yamada, Kentaro, Kyo Noguchi, Takashi Komeno, Yousuke Furuta, & Akira Nishizono. (2015). Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis. The Journal of Infectious Diseases. 213(8). 1253–1261. 72 indexed citations

18.

Safronetz, David, Kyle Rosenke, Jonna B. Westover, et al.. (2015). The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Scientific Reports. 5(1). 14775–14775. 92 indexed citations

19.

Komeno, Takashi, Hiroshi Nishikawa, Atsushi Yoshida, et al.. (2013). Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase. Antimicrobial Agents and Chemotherapy. 57(11). 5202–5208. 154 indexed citations

20.

Takahata, Masahiro, Yoshiko Fukuda, Yuko Ito, et al.. (2007). In vitro antibacterial activity of garenoxacin. 55. 1–20. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact